Gerard J. Platenburg
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Gerard J.
Platenburg was the founder of Prosensa Holding NV, serving as Chief Executive & Development Officer from 2002 to 2009.
Dr. Platenburg is the founder of ProQR Therapeutics NV, serving as Chief Scientific Officer & Executive Director since 2024.
Former job at ISA Pharmaceuticals BV as Chief Executive Officer from 2009 to 2014.
Former job at Pharming NV as Principal.
Education includes graduate and doctorate degrees from the University of Leiden, both conferred in 1987.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROQR THERAPEUTICS N.V. 0,78 % | 18/03/2026 | 824 388 ( 0,78 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Fondateur | 21/02/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Directeur Général | 01/01/2014 |
| PROSENSA HOLDING NV | Directeur Général | 01/05/2009 |
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for the treatment of a range of medical indications | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for the treatment of a range of medical indications | Commercial Services |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national